The SIGMA Consortium’s VISION is to provide best evidence on the use, benefits and harms of medications, vaccines and devices for the betterment of public health and patient care.

Its MISSION is to provide trusted pharmacoepidemiologic and real-world evidence (PE/RWE) research through a European federated professional network of excellence based on the ENCePP Code of Conduct. The SIGMA consortium welcomes collaborations with other groups and networks.